You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selective proteasome inhibition

Showing 1 - 25 of 5,981
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure With Preserved Ejection Fraction Trial (IMR-687, IMR-687 Placebo)

Withdrawn
  • Heart Failure With Preserved Ejection Fraction
  • (no location specified)
May 23, 2022

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

Kidney Transplantation, Renal Transplant Recipients Trial in Atlanta (Lulizumab, Tacrolimus, Thymoglobulin®)

Not yet recruiting
  • Kidney Transplantation
  • Renal Transplant Recipients
  • Lulizumab
  • +5 more
  • Atlanta, Georgia
    Emory University Hospital
Sep 22, 2021

Proteasome Inhibition

Completed
  • Heart Failure
  • Multiple Myeloma
    • Philadelphia, Pennsylvania
    • +1 more
    Sep 10, 2020

    Autoimmune Hepatitis Trial in Indianapolis (zetomipzomib, )

    Recruiting
    • Autoimmune Hepatitis
    • Indianapolis, Indiana
      Indiana University
    Jan 13, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 3, 2022

    Biliary Tract Cancer Trial in London (KA2507)

    Withdrawn
    • Biliary Tract Cancer
    • London, United Kingdom
      Cancer Research UK and UCL Cancer Trials Centre
    Jan 30, 2021

    Non Small Cell Lung Cancer Trial in Los Angeles (Apricoxib)

    Terminated
    Has Results
    • Non Small Cell Lung Cancer
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Sep 21, 2020

    Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

    Completed
    Has Results
    • Acute Leukemia
    • +4 more
    • Atlanta, Georgia
      Northside Hospital
    Sep 1, 2021

    Lupus Nephritis, Systemic Lupus Erythematosus Trial in Worldwide (KZR-616)

    Active, not recruiting
    • Lupus Nephritis
    • Systemic Lupus Erythematosus
    • Los Angeles, California
    • +49 more
    Mar 10, 2022

    Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

    Withdrawn
    • Liposarcoma
    • +4 more
    • New York, New York
      Columbia University Medical Center
    Nov 24, 2020

    JAK-i on RA B-lymphocytes Tolerance and Disease Resolution

    Recruiting
    • Rheumatoid Arthritis
    • B lymphocyte profiling
    • Rome, Italy
      Division of Clinical Immunology, Fondazione Policlinico Universi
    Feb 22, 2023

    Healthy Trial in Philadelphia (Blood draw)

    Active, not recruiting
    • Healthy
    • Blood draw
    • Philadelphia, Pennsylvania
      The Clinical Translational Research Center (CTRC) at the Hospita
    Aug 16, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Des Moines, Iowa
    • +8 more
    Jan 12, 2023

    Cerebral Palsy, Spasticity, Muscle Trial in Ankara (EXOPULSE Mollii Suit)

    Recruiting
    • Cerebral Palsy
    • Spasticity, Muscle
    • EXOPULSE Mollii Suit
    • Ankara, Turkey
      Gazi University
    Oct 30, 2023

    Healthy Trial in Copenhagen (Escitalopram 20 mg, Placebo)

    Active, not recruiting
    • Healthy
    • Escitalopram 20 mg
    • Placebo
    • Copenhagen, Denmark
      Neurobiology Research Unit
    Jul 14, 2022

    The Sense of Small and Inhibition in Obesity

    Recruiting
    • Obesity
    • Experimental Task
    • Piancavallo, VCO, Italy
      IRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe
    Mar 3, 2023

    Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +11 more
    • KEYTRUDA®
    • (no location specified)
    Nov 17, 2023

    Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

    Active, not recruiting
    • Breast Cancer
    • Renal Cell Carcinoma
    • IPI-549 (eganelisib)
    • +3 more
    • Chandler, Arizona
    • +23 more
    Apr 1, 2022

    Type 2 Diabetes Trial in Göteborg (Tadalafil)

    Terminated
    • Type 2 Diabetes
    • Göteborg, Sweden
      The Wallenberg Laboratory, Dept of Molecular and Clinical Medici
    Feb 10, 2020

    Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

    Not yet recruiting
    • Oligometastatic Prostate Cancer
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Jun 14, 2023

    Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

    Terminated
    • Multiple Myeloma
    • Milano, Italy
    • +10 more
    Jul 4, 2022

    Neuropathic Pain Trial in Saint Louis (Ondansetron 8mg with Saline & Tariquidar, Ondansetron 16mg with Saline & Tariquidar)

    Terminated
    • Neuropathic Pain
    • Ondansetron 8mg with Saline & Tariquidar
    • Ondansetron 16mg with Saline & Tariquidar
    • Saint Louis, Missouri
      Washington University in St. Louis
    Mar 28, 2022

    Cardiovascular Complications of Carfilzomib Treatment

    Active, not recruiting
    • Multiple Myeloma
      • Athens, Greece
        Department of Clinical Therapeutics, "Alexandra" General Hospita
      Apr 27, 2021

      Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

      Not yet recruiting
      • Depression
      • Serotonin Deficiency
      • Pharmacological agent: Citalopram
      • Placebo
      • Kelowna, British Columbia, Canada
        University of British Columbia, Okanagan Campus
      Jul 19, 2023